Albertsons Companies, Inc. filings document material events for a public food and drug retailer, including furnished operating results, Regulation FD disclosures, board changes, and financing transactions. Recent 8-Ks cover quarterly and annual financial results, opioid-related claim disclosures, director appointments and resignations, and senior note offerings or refinancings involving the company and subsidiary co-issuers such as Safeway Inc., New Albertsons L.P., Albertson's LLC and Albertsons Safeway LLC.
The filing record also describes capital-structure terms for senior notes due 2031, 2032 and 2034, use of proceeds for debt refinancing and revolver repayment, stockholder-agreement governance matters, Class A common stock ownership references, exhibits, and Inline XBRL cover-page data.
Albertsons Companies, Inc. reported that President & CFO Sharon McCollam acquired multiple awards of Dividend Equivalent Units on August 7, 2026. The awards total 474, 484, 916, 1,835 and 2,564 units, each tied to either performance-based or time-based restricted stock units and Class A common stock. According to the footnotes, these units were credited as dividend equivalents based on the $0.17 per share quarterly dividend and will vest and settle together with the underlying RSU awards.
Bruno Frank W reported acquisition or exercise transactions in this Form 4 filing.
Albertsons Companies director Frank W. Bruno received a grant of 154 Dividend Equivalent Units tied to Class A common stock on 2026-08-07. These units were credited as restricted stock units representing quarterly dividend equivalents of $0.17 per share on unvested RSUs and will vest and settle along with the underlying awards, bringing his directly held RSU-based units to 11,002.
DHANDA ANUJ reported acquisition or exercise transactions in this Form 4 filing.
Albertsons Companies executive Anuj Dhanda, Chief Tech & Transformation Officer, received multiple awards of Dividend Equivalent Units on August 7, 2026. These units were credited as restricted stock units (RSUs) tied to existing performance-based and time-based RSUs and to Class A common stock. According to the footnotes, each award reflects a quarterly dividend equivalent of $0.17 per share of common stock and will vest and settle together with the corresponding underlying RSU or stock awards.
TURNER BRIAN KEVIN reported acquisition or exercise transactions in this Form 4 filing.
Albertsons Companies, Inc. director Brian Kevin Turner reported an automatic grant of 154 Dividend Equivalent Units on 2026-08-07. These units are RSUs credited as dividend equivalents on his unvested RSUs and will vest and settle with those underlying awards. Following this grant, he holds 11,002 Dividend Equivalent Units directly.
Albertsons Companies, Inc. director Mary E. Stone reported an acquisition of 154 Dividend Equivalent Units tied to unvested restricted stock units on August 7, 2026. These units were credited as quarterly dividend equivalents based on a $0.17 per share common stock dividend and will vest and settle in step with the underlying RSU awards. Following this grant, Stone directly holds 11,002 Dividend Equivalent/RSU-linked units representing the right to receive an equivalent number of shares of Class A common stock upon vesting and settlement.
Albertsons Companies, Inc. reported results from its August 6, 2026 annual stockholder meeting and related charter changes. Stockholders approved amendments to the certificate of incorporation to replace certain supermajority requirements with a majority voting standard for changing board size, removing directors, and amending bylaws, and to limit the liability of certain officers to the fullest extent permitted by Delaware law. A certificate of amendment and an amended and restated certificate of incorporation were filed on August 11, 2026 to implement these changes. All director nominees were elected, Deloitte & Touche LLP was ratified as auditor for the fiscal year ending February 27, 2027, and executive compensation was approved on an advisory basis. A stockholder proposal requesting a report on human rights policy and due diligence did not pass.
Albertsons Companies, Inc. President & CFO Sharon McCollam purchased 9,000 shares of Class A common stock on July 31, 2026 at $11.48 per share. Following this open-market or private transaction, she directly holds 567,051 Albertsons Class A common shares.
Albertsons Companies, Inc. insider Susan Morris, Chief Executive Officer and director, reported purchases of a total of 39,409 shares of Class A common stock on July 28, 2026, in transactions described as purchases in open market or private transactions at prices of $11.455 and $11.377 per share; the Rule 10b5-1 checkbox was not marked and the purchases were reported as directly owned.
Albertsons Companies, Inc. executive Thomas M. Moriarty, EVP, M&A and Corporate Affairs, reported purchasing 170,500 shares of Class A common stock on July 27, 2026 at $11.509 per share. Following this transaction, his reported holdings total 308,946 shares, including shares held in Family Trusts, with beneficial ownership disclaimed for 45,725 of those trust-held shares.
Albertsons Companies, Inc. reported first-quarter fiscal 2026 Net sales and other revenue of $24,941.6 million, essentially flat year over year, while identical sales excluding fuel declined 0.8%. Digital sales grew 13%, with continued strength in eCommerce, loyalty and media initiatives.
Net income fell to $84.7 million from $236.4 million, and diluted EPS declined to $0.17 from $0.41, driven by lower gross margin, higher selling and administrative expenses and increased interest expense. Adjusted net income was $210.3 million (Adjusted EPS $0.42) versus $318.9 million ($0.55) and Adjusted EBITDA was $1,013.2 million versus $1,111.0 million.
Operating cash flow was strong at $728.9 million. The company invested $522.1 million in capital expenditures, including remodels, new stores and technology, paid $84.0 million in dividends and repurchased 13.4 million shares for $226.5 million. Total debt was $9,162.8 million, including $700.0 million outstanding under the ABL Facility. Albertsons also detailed an opioid-related settlement framework with a previously recorded loss of $773.8 million and related liabilities of $273.1 million current and $500.7 million long term as of June 20, 2026.